[Federal Register Volume 90, Number 217 (Thursday, November 13, 2025)]
[Notices]
[Pages 50944-50945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-19872]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2025-0783]
Meeting of the Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). Time will be available for public comment.
[[Page 50945]]
DATES: The meeting will be held on December 4, 2025, from 9:00 a.m. to
5:30 p.m., EST and December 5, 2025, from 8 a.m. to 5 p.m., EST (times
subject to change; see the ACIP website for updates: https://www.cdc.gov/acip/meetings/index.html). The meeting is expected to be
held at the Centers for Disease Control and Prevention, with a virtual
option. Written comments must be received between November 13-24, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0783, by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: ACIP Secretariat, ACIP Meeting, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H21-12, Atlanta,
Georgia 30329-4027. Attn: Docket No. CDC-2025-0783.
Instructions: All submissions received must include the
Agency name and docket number. For access to the docket to read
background documents or comments received, go to https://www.regulations.gov.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at https://www.cdc.gov/acip/index.html.
FOR FURTHER INFORMATION CONTACT: ACIP Secretariat, Advisory Committee
on Immunization Practices, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21-12, Atlanta, Georgia, 30329-4027.
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee on Immunization Practices is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children program, along with schedules regarding dosing interval,
dosage, and contraindications to administration of vaccines. Further,
under applicable provisions of the Affordable Care Act and section 2713
of the Public Health Service Act, immunization recommendations of ACIP
that have been adopted by the Director, CDC, and appear on CDC
immunization schedules generally must be covered by applicable health
plans.
Matters to be Considered: The agenda will include discussions on
vaccine safety, the childhood and adolescent immunization schedule, and
hepatitis B vaccines. The agenda will include updates on ACIP
workgroups. Recommendation votes may be scheduled for hepatitis B
vaccines. Vaccines for Children (VFC) votes may be scheduled for
hepatitis B vaccines. Agenda items are subject to change as priorities
dictate. For more information on the meeting agenda, visit https://www.cdc.gov/acip/index.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website
https://www.cdc.gov/acip.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near-duplicate
examples of mass-mail campaigns. CDC will carefully consider all
comments submitted into docket.
Written Public Comment: The docket will be opened to receive
written comments November 13-24, 2025. Written comments must be
received no later than November 24, 2025.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes, including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the December 4-5, 2025 ACIP meeting must
submit a request at https://www.cdc.gov/acip/meetings/index.html
between November 13-24, 2025, and no later than 11:59 p.m. EST,
November 24, 2025, according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
random draw to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by December 1, 2025. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may speak only once per meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2025-19872 Filed 11-12-25; 8:45 am]
BILLING CODE 4163-18-P